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EFFECTS OF BRONCHIAL ARTERY INFUSION THERAPY ON
    THE PATIENTS WITH MULTIPLE PULMONARY
    MATASTASES FROM RENAL CELL CARCINOMA
Masashi ANDo， Keiichi MATsuMoTo， Tadao KAKizoE and Yasunari NisHio
          National Cancer Center HospitalひηJo即エ）ivisiOll
  N’Ve treated 9 patients who had pulmonary metastases from renal cell carcinoma with bronchial
arterial infusion therapy （BAI）， Of9 cases， BAI was performed 32 times using Seldinger’s angiographic
techn｛que， The anti－cancer drugs were in魚sed through arl angiographic catheter into the bronchial
artery by a one shot infusion lasting from 10 to 20 minutes， The drugs used for BAI were MMC，
Carbazilquinone （CQ）， ACNU and adriamycin（ADM）． The deg． age o’f the drugs was MMC 10－20
mg， COev 3－6 mg， ACNU 100 mg， ADM 20－40 mg．
  Bronchlal arteriography revealed irregular hypervascu］arity and tumor stain in most of the cases．
  An effective response （reduction rate＞20％） was observed in 4 patients （33．30／，） metastatic foci
had disappeared completely’in one of these 4 cases． The other 5 patients had no change or had pro－
gression of disease． No serious complication was observed．























754 泌尿紀要 28巻 6号．1982年
に肺転移をきたした症例である．男8例，女1例，年
齢は48歳から63歳までで平均53歳8ヵ月であった．摘






















 1回注入量はMMCが10 mgから20 mg， Gqは











Table 1． Drug used for BAI and no． of infusion      o































































Table 2．Results of bronchial artery infusion
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of B A I （month）
Remarks
lK．S． M 53皿MMC 10mg×4 P．R．49 alive
           CQ 6mgX3
           ACNU 100mgx2
           ADM
2 E，H． F 47 IV CQ
3Y．S． M 51皿CQ
           ADM
4 S．Y． M 51 rv MMC
5 T．U． M 48 rv MMC
           CQ
6 B．K， M 56 unknoun M M C
7 H，Y， M 54 IV MMC
8 NI． M 63 IV MMC
9 T．A． M 59 M MMC
20mgX1
6mgXl N．C． 2 dead
6mgX4 M．R． 38 alive
40mgX 1
10mgX5 M．R． 18 alive
16mgX3 N．C． 13 alive
8mgX1
20mgXl N．C． 9 dead
16mgX2 N．C． 4 alive
20mgX2 N．C． 4 dead

























Fig． 1． Selective left bronchial arteriography
    of case 4． Note marked vascularity






Fig． 2． Selective right bronchial arteriography
    of case 6． lndicated lesions have poor






れは，MMC， CQ， ACNU， ADMの4種の薬剤を使
用した． MMC使用例は有効例が多かった．今のと














よる副作用は初期のMMC 20 mgを生食水20 ccに
溶解し3分間で注入していた高濃度投与症例で，
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